Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8
- PMID: 16339408
- DOI: 10.1056/NEJMe058314
Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8
Comment in
-
Expression of concern reaffirmed.N Engl J Med. 2006 Mar 16;354(11):1193. doi: 10.1056/NEJMe068054. Epub 2006 Feb 22. N Engl J Med. 2006. PMID: 16495386 No abstract available.
-
Response to expression of concern regarding VIGOR study.N Engl J Med. 2006 Mar 16;354(11):1196-9. doi: 10.1056/NEJMc066096. Epub 2006 Feb 22. N Engl J Med. 2006. PMID: 16495387 No abstract available.
-
Response to expression of concern regarding VIGOR study.N Engl J Med. 2006 Mar 16;354(11):1196-9. N Engl J Med. 2006. PMID: 16544387 No abstract available.
Expression of concern for
-
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528. doi: 10.1056/NEJM200011233432103. N Engl J Med. 2000. PMID: 11087881 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources